Kidney Disease Market Forecast 2026–2035: Data Trends and Industry Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the kidney disease market from 2026–2035 with trusted insights from The Business Research Company

How much is the Kidney Disease Market valued at in 2026, and what valuation is forecast for 2030?

The kidney disease market size has shown significant expansion in recent years. It is anticipated to increase from $114.39 billion in 2025 to $121.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. The historical rise can be attributed to the rising prevalence of chronic kidney disease, an increasing incidence of diabetes and hypertension, the established use of dialysis and medication therapies, the growth in hospital-based renal care, and the expanding availability of diagnostic testing.

The kidney disease market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $159.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected growth is driven by several factors, including a globally aging demographic with elevated renal risks, the growing embrace of home-based dialysis solutions, increased financial commitments to kidney disease research, an intensified focus on proactive screening initiatives, and broader availability of kidney care services in developing economies. Key trends anticipated during this period encompass an heightened emphasis on early diagnosis and effective disease management, a surge in the utilization of dialysis and renal replacement therapies, a growing need for tailored kidney disease treatments, the proliferation of multidisciplinary care approaches for individuals with kidney conditions, and enhanced patient understanding coupled with preventative health efforts.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Drivers Are Influencing The Growth Of The Kidney Disease Market?

The rising occurrence of kidney ailments is anticipated to drive expansion within the kidney disease market moving ahead. These conditions encompass various disorders impacting kidney function and structure. Medications for kidney disorders serve to decrease blood pressure and protein excretion in patients, thereby retarding kidney damage progression, alleviating symptoms, and averting complications. As an illustration, in June 2023, Kidney Research UK, a charitable entity based in the UK dedicated to advancing the comprehension, prevention, and treatment of kidney diseases, reported that approximately 7.19 million individuals in the UK suffered from chronic kidney disease in 2023. This figure accounts for over 10% of the UK population and is projected to reach 7.61 million people by 2033. Consequently, the growing frequency of kidney diseases is fueling the development of the kidney disease market.

What Segments Are Included Within The Kidney Disease Market?

The kidney disease market covered in this report is segmented –

1) By Treatment: Medication, Dialysis, Surgery, Other Treatments

2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Medication: Antihypertensives, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Vitamin D Analogs, Immunosuppressants

2) By Dialysis: Hemodialysis, Peritoneal Dialysis

3) By Surgery: Kidney Transplant, Nephrectomy, Renal Artery Bypass, Ureteral Surgery

4) By Other Treatments: Lifestyle And Dietary Modifications, Renal Replacement Therapy, Palliative Care

Which Trends Are Influencing The Development Of The Kidney Disease Market?

Leading companies in the kidney disease market are increasingly focusing on integrating technology-driven innovations, such as compact, cartridge-based hemodialysis systems, to enhance treatment flexibility, patient convenience, and workflow efficiency. These compact, cartridge-based hemodialysis systems are portable dialysis devices that utilize disposable dialysate cartridges instead of traditional bagged fluids, enabling capabilities like automated dialysate preparation, simplified setup, and improved suitability for therapy conducted at home. For instance, in November 2024, Quanta Dialysis Technologies, a UK-based dialysis technology company, received FDA clearance for the Quanta Dialysis System. This cartridge-based hemodialysis system is specifically designed to support home hemodialysis and flexible deployment in various care settings, distinguished by its small footprint, on-demand dialysate generation, and an intuitive touchscreen interface. The Quanta Dialysis System ultimately enhances patient autonomy, streamlines treatment delivery, and improves operational efficiency across all dialysis environments.

Who Are The Core Companies Influencing Trends In The Kidney Disease Market?

Major companies operating in the kidney disease market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Bristol-Myers Squibb Company, AbbVie Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Kyowa Kirin Co. Ltd., Vertex Pharmaceuticals Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Lupin Limited, Aurobindo Pharma Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Kidney Disease Market?

North America was the largest region in the kidney disease market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Kidney Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Browse Through More Reports Similar to the Global Kidney Disease Market 2026, By The Business Research Company

Rare Kidney Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

Chronic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Diabetic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795